Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tifinorphine hydrochloride for relapse prevention after opioid detoxification
CTR20150565Phase 2Active
- Sponsor
- Beijing Ziduhongye Technology Development
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tifinorphine in opioid use disorder (OUD), sponsored by Beijing Ziduhongye Technology Development. Started Sep 2015; status: active.
02
Drugs
tifinorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on CTR20150565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150565.